Literature DB >> 15541358

Heterogeneity within and between primary colorectal carcinomas and matched metastases as revealed by analysis of Ki-ras and p53 mutations.

Ida Albanese1, Angelo Giuseppe Scibetta, Manuela Migliavacca, Antonio Russo, Viviana Bazan, Rosa Maria Tomasino, Paolo Colomba, Marcello Tagliavia, Mario La Farina.   

Abstract

Analysis of the genetic status of Ki-ras and p53 in primary colorectal carcinomas and matched colorectal liver metastasis from 30 patients reveals an overall heterogeneity both within and between the two tumoral tissues. Both genes were found mutated with a similar frequency in both tissues; however, identical mutations in primary tumor and matched metastasis were found less frequently in the case of the Ki-ras than the p53 gene. Only in three cases the same p53 and Ki-ras mutations found in the primary tumor were found also in the metastasis. In several metastatic specimens the DNA bearing a mutation detected also in the primary tumor appears significantly less abundant than the wild-type DNA. These data are discussed in the light of current models of primary tumor/metastasis relationships.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15541358     DOI: 10.1016/j.bbrc.2004.10.111

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  45 in total

1.  Comparative genomic analysis of primary versus metastatic colorectal carcinomas.

Authors:  Efsevia Vakiani; Manickam Janakiraman; Ronglai Shen; Rileen Sinha; Zhaoshi Zeng; Jinru Shia; Andrea Cercek; Nancy Kemeny; Michael D'Angelica; Agnes Viale; Adriana Heguy; Philip Paty; Timothy A Chan; Leonard B Saltz; Martin Weiser; David B Solit
Journal:  J Clin Oncol       Date:  2012-06-04       Impact factor: 44.544

2.  Comparison of KRAS mutation status between primary tumor and metastasis in Chinese colorectal cancer patients.

Authors:  Zhe-Zhen Li; Long Bai; Feng Wang; Zi-Chen Zhang; Fang Wang; Zhao-Lei Zeng; Jun-Bo Zeng; Dong-Sheng Zhang; Feng-Hua Wang; Zhi-Qiang Wang; Yu-Hong Li; Jian-Yong Shao; Rui-Hua Xu
Journal:  Med Oncol       Date:  2016-06-06       Impact factor: 3.064

Review 3.  Pragmatic issues in biomarker evaluation for targeted therapies in cancer.

Authors:  Armand de Gramont; Sarah Watson; Lee M Ellis; Jordi Rodón; Josep Tabernero; Aimery de Gramont; Stanley R Hamilton
Journal:  Nat Rev Clin Oncol       Date:  2014-11-25       Impact factor: 66.675

Review 4.  Current therapy of advanced colorectal cancer according to RAS/RAF mutational status.

Authors:  Gábor Lakatos; Claus-Henning Köhne; György Bodoky
Journal:  Cancer Metastasis Rev       Date:  2020-12       Impact factor: 9.264

Review 5.  Concordance of predictive markers for EGFR inhibitors in primary tumors and metastases in colorectal cancer: a review.

Authors:  Jara M Baas; Lisanne L Krens; Henk-Jan Guchelaar; Hans Morreau; Hans Gelderblom
Journal:  Oncologist       Date:  2011-07-08

6.  A target selection of somatic hypermutations is regulated similarly between T and B cells upon activation-induced cytidine deaminase expression.

Authors:  Ai Kotani; Il-Mi Okazaki; Masamichi Muramatsu; Kazuo Kinoshita; Nasim A Begum; Toshiharu Nakajima; Hirohisa Saito; Tasuku Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-14       Impact factor: 11.205

7.  Degraded DNA may induce discordance of KRAS status between primary colorectal cancer and corresponding liver metastases.

Authors:  Yuka Kaneko; Hidekazu Kuramochi; Go Nakajima; Yuji Inoue; Masakazu Yamamoto
Journal:  Int J Clin Oncol       Date:  2013-01-09       Impact factor: 3.402

8.  Putative precursor cancer cells in human colorectal cancer tissue.

Authors:  Teodora E Goranova; Masayuki Ohue; Kikuya Kato
Journal:  Int J Clin Exp Pathol       Date:  2008-07-14

9.  Comparison of KRAS/BRAF mutations between primary tumors and serum in colorectal cancer: Biological and clinical implications.

Authors:  Xingxiang Pu; Zhizhong Pan; Ying Huang; Ying Tian; Hongqiang Guo; Lin Wu; Xuexing He; Xinggui Chen; Shaodan Zhang; Tongyu Lin
Journal:  Oncol Lett       Date:  2012-10-10       Impact factor: 2.967

Review 10.  Management of resectable colorectal lung metastases.

Authors:  Sing Yu Moorcraft; George Ladas; Anne Bowcock; Ian Chau
Journal:  Clin Exp Metastasis       Date:  2015-12-10       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.